It doesn’t end there, however, as you may also have to go to a pharmacy and deal with everything that entails.
One Medical went public in early 2020 at around $22 per share. Value peaked in February 2021 at $58.70 but has since slid considerably. The all-cash deal is valued at roughly $3.9 billion, or $18 per share. That represents nearly a 77 percent premium over the stock’s closing price of $10.18 at the end of trading on Wednesday. The acquisition is subject to regulatory and shareholder approval as well as customary closing conditions. Amir Dan Rubin will remain CEO of One Medical once the deal is complete. Image credit: Tima Miroshnichenko, Artem Podrez
